Identification of catalytically active domain epitopes in neuraminidase protein of H9N2 subtype of avian influenza virus

References

• Air, G.M. (2012). Influenza neuraminidase. Influenza and Other Respiratory Viruses, 6, 245–256.
   PubMed Web of Science ®Google Scholar
• Alexander, D.J. (2007). An overview of the epidemiology of avian influenza. Vaccine, 25, 5637–5644.
   PubMed Web of Science ®Google Scholar
• Barman, S., Adhikary, L., Chakrabarti, A.K., Bernas, C., Kawaoka, Y. & Nayak, D.P. (2004). Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding. Journal of Virology, 78, 5258–5269.
   PubMed Web of Science ®Google Scholar
• Beard, K.R., Brendish, N.J. & Clark, T.W. (2018). Treatment of influenza with neuraminidase inhibitors. Current Opinion in Infectious Diseases, 31, 514–519.
   PubMed Web of Science ®Google Scholar
• Bi, Y., Chen, Q., Wang, Q., Chen, J., Jin, T., Wong, G., Quan, C., Liu, J., Wu, J., Yin, R., Zhao, L., Li, M., Ding, Z., Zou, R., Xu, W., Li, H., Wang, H., Tian, K., Fu, G., Huang, Y., Shestopalov, A., Li, S., Xu, B., Yu, H., Luo, T., Lu, L., Xu, X., Luo, Y., Liu, Y., Shi, W., Liu, D. & Gao, G.F. (2016). Genesis, evolution and prevalence of H5N6 avian influenza viruses in China. Cell Host & Microbe, 20, 810–821.
   PubMed Web of Science ®Google Scholar
• Butt, K.M., Smith, G.J., Chen, H., Zhang, L.J., Leung, Y.H., Xu, K.M., Lim, W., Webster, R.G., Yuen, K.Y., Peiris, J.S. & Guan, Y. (2005). Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. Journal of Clinical Microbiology, 43, 5760–5767.
   PubMed Web of Science ®Google Scholar
• Creytens, S., Pascha, M.N., Ballegeer, M., Saelens, X. & de Haan, C.A.M. (2021). Influenza neuraminidase characteristics and potential as a vaccine target. Frontiers in Immunology, 12, 786617.
   PubMed Web of Science ®Google Scholar
• Deroo, T., Jou, W.M. & Fiers, W. (1996). Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine, 14, 561–569.
   PubMed Web of Science ®Google Scholar
• Guan, Y., Shortridge, K.F., Krauss, S. & Webster, R.G. (1999). Molecular characterization of H9N2 influenza viruses: were they the donors of the “internal” genes of H5N1 viruses in Hong Kong? Proceedings of the National Academy of Sciences, 96, 9363–9367.
   PubMed Web of Science ®Google Scholar
• Gubareva, L.V., Kaiser, L. & Hayden, F.G. (2000). Influenza virus neuraminidase inhibitors. The Lancet, 355, 827–835.
   PubMed Web of Science ®Google Scholar
• Homme, P.J. & Easterday, B.C. (1970). Avian influenza virus infections. I. Characteristics of influenza A/Turkey/Wisconsin/1966 virus. Avian Diseases, 14, 66–74.
   PubMedGoogle Scholar
• Huang, X., Huang, J., Yin, G., Cai, Y., Chen, M., Hu, J. & Feng, X. (2022). Identification of NP protein-specific B-cell epitopes for H9N2 subtype of avian influenza virus. Viruses, 14, 1172.
   PubMed Web of Science ®Google Scholar
• Huang, X., Yin, G., Cai, Y., Hu, J., Huang, J., Liu, Q., et al. (2022). Identification of unique and conserved neutralizing epitopes of vestigial esterase domain in HA protein of the H9N2 subtype of avian influenza virus. Viruses, 14, 2739.
   PubMed Web of Science ®Google Scholar
• Hutchinson, E.C., Charles, P.D., Hester, S.S., Thomas, B., Trudgian, D., Martinez-Alonso, M. & Fodor, E. (2014). Conserved and host-specific features of influenza virion architecture. Nature Communications, 5, 4816.
   PubMed Web of Science ®Google Scholar
• Ison, M.G. (2017). Antiviral treatments. Clinics in Chest Medicine, 38, 139–153.
   PubMed Web of Science ®Google Scholar
• Javanian, M., Barary, M., Ghebrehewet, S., Koppolu, V., Vasigala, V. & Ebrahimpour, S. (2021). A brief review of influenza virus infection. Journal of Medical Virology, 93, 4638–4646.
   PubMed Web of Science ®Google Scholar
• Jin, F., Dong, X., Wan, Z., Ren, D., Liu, M., Geng, T., Jin, F., Dong, X., Wan, Z., Ren, D., Liu, M., Geng, T., Zhang, J., Gao, W., Shao, H., Qin, A., & Ye, J. (2019). A single mutation N166D in hemagglutinin affects antigenicity and pathogenesis of H9N2 avian influenza virus. Viruses, 11, 709.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick Roubidoux, E., McMahon, M., Carreno, J.M., Capuano, C., Jiang, K., Simon, V., van Bakel, H., Wilson, P. & Krammer, F. (2021). Identification and characterization of novel antibody epitopes on the N2 neuraminidase. mSphere, 6, e00958–20.
   PubMed Web of Science ®Google Scholar
• Kosik, I., Angeletti, D., Gibbs, J.S., Angel, M., Takeda, K., Kosikova, M., Nair, V., Hickman, H.D., Xie, H., Brooke, C.B. & Yewdell, J.W. (2019). Neuraminidase inhibition contributes to influenza A virus neutralization by anti-hemagglutinin stem antibodies. Journal of Experimental Medicine, 216, 304–316.
   PubMed Web of Science ®Google Scholar
• Kundu, A., Avalos, R.T., Sanderson, C.M. & Nayak, D.P. (1996). Transmembrane domain of influenza virus neuraminidase, a type II protein, possesses an apical sorting signal in polarized MDCK cells. Journal of Virology, 70, 6508–6515.
   PubMed Web of Science ®Google Scholar
• Lam, T.T., Wang, J., Shen, Y., Zhou, B., Duan, L., Cheung, C.L., Ma, C., Lycett, S.J., Leung, C.Y., Chen, X., Li, L., Hong, W., Chai, Y., Zhou, L., Liang, H., Ou, Z., Liu, Y., Farooqui, A., Kelvin, D.J., Poon, L.L., Smith, D.K., Pybus, O.G., Leung, G.M., Shu, Y., Webster, R.G., Webby, R.J., Peiris, J.S., Rambaut, A., Zhu, H. & Guan, Y. (2013). The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature, 502, 241–244.
   PubMed Web of Science ®Google Scholar
• Leyva-Grado, V.H., Tan, G.S., Leon, P.E., Yondola, M. & Palese, P. (2015). Direct administration in the respiratory tract improves efficacy of broadly neutralizing anti-influenza virus monoclonal antibodies. Antimicrobial Agents and Chemotherapy, 59, 4162–4172.
   PubMed Web of Science ®Google Scholar
• Li, C.H., Zhou, X.Z. & Li, M.X. (2004). Discoveries of avian influenza A(H9N2) virus in chickens and men infected by H9N2 virus in Guangzhou area. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, 18, 213–214.
   PubMedGoogle Scholar
• Li, F., Ma, C. & Wang, J. (2015). Inhibitors targeting the influenza virus hemagglutinin. Current Medicinal Chemistry, 22, 1361–1382.
   PubMed Web of Science ®Google Scholar
• Liu, M., Li, X., Yuan, H., Zhou, J., Wu, J., Bo, H., Xia, W., Xiong, Y., Yang, L., Gao, R., Guo, J., Huang, W., Zhang, Y., Zhao, X., Zou, X., Chen, T., Wang, D., Li, Q., Wang, S., Chen, S., Hu, M., Ni, X., Gong, T., Shi, Y., Li, J., Zhou, J., Cai, J., Xiao, Z., Zhang, W., Sun, J., Li, D., Wu, G., Feng, Z., Wang, Y., Chen, H. & Shu, Y. (2015). Genetic diversity of avian influenza A (H10N8) virus in live poultry markets and its association with human infections in China. Scientific Reports, 5, 7632.
   PubMed Web of Science ®Google Scholar
• McKimm-Breschkin, J.L. (2005). Management of influenza virus infections with neuraminidase inhibitors. Treatments in Respiratory Medicine, 4, 107–116.
   PubMedGoogle Scholar
• Powell, H. & Pekosz, A. (2020). Neuraminidase antigenic drift of H3N2 clade 3c.2a viruses alters virus replication, enzymatic activity and inhibitory antibody binding. PLoS Pathogens, 16, e1008411.
   PubMed Web of Science ®Google Scholar
• Shcherbik, S., Carney, P., Pearce, N., Stevens, J., Dugan, V.G., Wentworth, D.E. & Bousse, T. (2018). Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines. Virology, 522, 65–72.
   PubMed Web of Science ®Google Scholar
• Song, W. & Qin, K. (2020). Human-infecting influenza A (H9N2) virus: a forgotten potential pandemic strain? Zoonoses and Public Health, 67, 203–212.
   PubMed Web of Science ®Google Scholar
• Sun, X., Li, Q., Wu, Y., Wang, M., Liu, Y., Qi, J., Vavricka, C.J. & Gao, G.F. (2014). Structure of influenza virus N7: the last piece of the neuraminidase “jigsaw” puzzle. Journal of Virology, 88, 9197–9207.
   PubMed Web of Science ®Google Scholar
• Swierczynska, M., Mirowska-Guzel, D.M. & Pindelska, E. (2022). Antiviral drugs in influenza. International Journal of Environmental Research and Public Health, 19, 3018.
   PubMed Web of Science ®Google Scholar
• Tan, J., O’Dell, G., Hernandez, M.M., Sordillo, E.M., Kahn, Z., Kriti, D., van Bakel, H., Ellebedy, A.H., Wilson, P.C., Simon, V., Krammer, F. & McMahon, M. (2022). Human anti-neuraminidase antibodies reduce airborne transmission of clinical influenza virus isolates in the Guinea Pig model. Journal of Virology, 96, e0142121.
   PubMed Web of Science ®Google Scholar
• Wan, H., Gao, J., Xu, K., Chen, H., Couzens, L.K., Rivers, K.H., Easterbrook, J.D., Yang, K., Zhong, L., Rajabi, M., Ye, J., Sultana, I., Wan, X.F., Liu, X., Perez, D.R., Taubenberger, J.K. & Eichelberger, M.C. (2013). Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses. Journal of Virology, 87, 9290–9300.
   PubMed Web of Science ®Google Scholar
• Wang, F., Wan, Z., Wu, J., Wang, Y., Fu, H., Shao, H., Qian, K., Gao, W., Ye, J. & Qin, A. (2021). A cross-reactive monoclonal antibody against neuraminidases of both H9N2 and H3N2 influenza viruses shows protection in mice challenging models. Frontiers in Microbiology, 12, 730449.
   PubMed Web of Science ®Google Scholar
• Wang, F., Wang, Y., Wan, Z., Shao, H., Qian, K., Ye, J. & Qin, A. (2020). Generation of a recombinant chickenized monoclonal antibody against the neuraminidase of H9N2 avian influenza virus. AMB Express, 10, 151.
   PubMed Web of Science ®Google Scholar
• Wang, F., Wu, J., Wang, Y., Wan, Z., Shao, H., Qian, K., Ye, J. & Qin, A. (2021). Identification of key residues involved in the neuraminidase antigenic variation of H9N2 influenza virus. Emerging Microbes & Infections, 10, 210–219.
   PubMed Web of Science ®Google Scholar
• Wang, J., Sun, Y. & Liu, S. (2022). Emerging antiviral therapies and drugs for the treatment of influenza. Expert Opinion on Emerging Drugs, 27, 389–403.
   PubMed Web of Science ®Google Scholar
• Yu, Y.N., Zheng, Y., Hao, S.S., Zhang, Z., Cai, J.X., Zong, M.M., et al. (2020). The molecular evolutionary characteristics of new isolated H9N2 AIV from East China and the function of vimentin on virus replication in MDCK cells. Virology Journal, 17, 78.
   PubMed Web of Science ®Google Scholar